Lifecore Biomedical, Inc.
LFCR
$6.38
$0.213.40%
NASDAQ
| 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | |
|---|---|---|---|---|---|
| Revenue | 35.15M | 32.56M | 24.71M | 37.89M | 35.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.15M | 32.56M | 24.71M | 37.89M | 35.70M |
| Cost of Revenue | 25.31M | 21.48M | 19.32M | 20.61M | 23.81M |
| Gross Profit | 9.85M | 11.08M | 5.39M | 17.27M | 11.89M |
| SG&A Expenses | 10.09M | 10.72M | 12.29M | 12.22M | 9.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.45M | 34.12M | 33.79M | 35.00M | 35.83M |
| Operating Income | -2.29M | -1.56M | -9.08M | 2.89M | -124.00K |
| Income Before Tax | -14.78M | -6.53M | -16.26M | -7.14M | 15.00M |
| Income Tax Expenses | -8.00K | 43.00K | -25.00K | -57.00K | 217.00K |
| Earnings from Continuing Operations | -14.77M | -6.57M | -16.23M | -7.09M | 14.79M |
| Earnings from Discontinued Operations | -- | -- | -- | 3.00K | 847.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.77M | -6.57M | -16.23M | -7.08M | 15.63M |
| EBIT | -2.29M | -1.56M | -9.08M | 2.89M | -124.00K |
| EBITDA | -217.00K | 489.00K | -7.09M | 4.64M | 1.88M |
| EPS Basic | -0.47 | -0.25 | -0.53 | -0.23 | 0.51 |
| Normalized Basic EPS | -0.14 | -0.11 | -0.28 | -0.13 | 0.32 |
| EPS Diluted | -0.47 | -0.25 | -0.53 | -0.23 | 0.42 |
| Normalized Diluted EPS | -0.14 | -0.11 | -0.28 | -0.13 | 0.27 |
| Average Basic Shares Outstanding | 37.02M | 34.36M | 30.86M | 30.55M | 30.49M |
| Average Diluted Shares Outstanding | 37.02M | 34.36M | 30.86M | 30.55M | 36.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |